Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:341 (9 August), doi:10.1136/bmj.327.7410.341-a
| The first 150 words of the full text of this article appear below. |
EDITORI am nice to drug representatives.
I accept shareholders of large multinational companies would not spend money on doctors if this was not profitablemake them prescribe more of their drugs. We as doctors should be aware of this.
Should I stop accepting gifts?1
Should I stop watching the US tennis open championship, with its huge advertisement for rofecoxib (Vioxx) on the centre court last year?
Compare drug representatives with political lobbyistshired hands who wine and dine politicians, take them to meetings at sporting events, fly them to exotic locations on fact finding tours, feed them at corporate lunches and political fundraising dinners. Doctors are not alone on the dancefloor at the porcupine ball.2
Let's put those lobbyists under the same scrutiny. Have you ever met an evidence based politician?
Over two weeks recently I used drug sponsorship to train 15 nurses as
asthma educators (they cannot prescribe) and
Steven Rudolphy, principal
Mount Sheridan Medical Practice, Cairns, Queensland 4868, Australia steven.rudolphy@mtsheridanmedical.com.au